7-hydroxy-5,11-dioxotetranorprostane-1,16-dioic acid has been researched along with Carcinoma, Squamous Cell in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bernstein, E; Burrows, F; Gitlitz, BJ; Milne, G; Otterson, GA; Santos, ES; Syto, M; Zaknoen, S | 1 |
| Bs, N; Dannenberg, AJ; Kandasamy, C; Kekatpure, VD; Kuriakose, MA; Milne, GL; Sunny, SP; Suresh, A; Wang, H; Zhou, XK | 1 |
| Boyle, JO; Dannenberg, AJ; Duffield-Lillico, AJ; Gross, ND; Kekatpure, VD; Lee, NY; Lippman, SM; Milne, G; Morrow, JD; Subbaramaiah, K; Zhou, XK | 1 |
| Boyle, JO; Dannenberg, AJ; Duffield-Lillico, AJ; Gross, ND; Morrow, JD; Moskowitz, CS; Subbaramaiah, K; Williams, MK | 1 |
1 trial(s) available for 7-hydroxy-5,11-dioxotetranorprostane-1,16-dioic acid and Carcinoma, Squamous Cell
| Article | Year |
|---|---|
A randomized, placebo-controlled, multicenter, biomarker-selected, phase 2 study of apricoxib in combination with erlotinib in patients with advanced non-small-cell lung cancer.
Topics: Adenocarcinoma; Adenocarcinoma, Bronchiolo-Alveolar; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cyclooxygenase 2 Inhibitors; Disease Progression; Double-Blind Method; Erlotinib Hydrochloride; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Prospective Studies; Prostaglandins; Protein Kinase Inhibitors; Pyrroles; Quinazolines; Sulfonamides; Survival Rate | 2014 |
3 other study(ies) available for 7-hydroxy-5,11-dioxotetranorprostane-1,16-dioic acid and Carcinoma, Squamous Cell
| Article | Year |
|---|---|
Elevated Levels of Urinary PGE-M Are Found in Tobacco Users and Indicate a Poor Prognosis for Oral Squamous Cell Carcinoma Patients.
Topics: Adult; Aged; Biomarkers, Tumor; Carcinoma, Squamous Cell; Chromatography, Liquid; Female; Head and Neck Neoplasms; Humans; Kaplan-Meier Estimate; Male; Mass Spectrometry; Middle Aged; Mouth Neoplasms; Prognosis; Proportional Hazards Models; Prostaglandins; Smoking; Squamous Cell Carcinoma of Head and Neck | 2016 |
Elevated levels of urinary prostaglandin e metabolite indicate a poor prognosis in ever smoker head and neck squamous cell carcinoma patients.
Topics: Aged; Aged, 80 and over; Biomarkers, Tumor; Carcinoma, Squamous Cell; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Staging; Prognosis; Prostaglandins; Retrospective Studies; Smoking; Survival Rate | 2009 |
Levels of prostaglandin E metabolite, the major urinary metabolite of prostaglandin E2, are increased in smokers.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Carcinoma, Squamous Cell; Case-Control Studies; Dinoprostone; Female; Head and Neck Neoplasms; Humans; Logistic Models; Male; Mass Spectrometry; Middle Aged; Prostaglandins; Prostaglandins E; Smoking | 2005 |